Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics

BACKGROUND: In dialysis patients, non-adherence to oral cinacalcet adds complexity to the control of secondary hyperparathyroidism. The present study aims to evaluate the use of intravenous calcimimetic, etelcalcetide, in the control of secondary hyperparathyroidism in patients adherent and non-adhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Arenas, Maria Dolores, Rodelo-Haad, Cristian, de Mier, M Victoria Pendón-Ruiz, Rodriguez, Mariano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986320/
https://www.ncbi.nlm.nih.gov/pubmed/33777366
http://dx.doi.org/10.1093/ckj/sfaa005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986320/
https://www.ncbi.nlm.nih.gov/pubmed/33777366
http://dx.doi.org/10.1093/ckj/sfaa005

Ejemplares similares